CTT promotes the differentiation of myeloid-derived suppressor cells (MDSCs) into mature dendritic cells and macrophages, activates antigen-presenting cells and natural killer (NK) cells, and induces Th1-dominant CD4+ T-cell-mediated antitumor immunity in numerous highly metastatic tumor models. The gene discussed is CD4; the disease is neoplasm.